Indian stock markets are set for an eventful session on Thursday, November 6, 2025, as several heavyweight companies announced their quarterly results and major corporate developments. Here’s a look at the top stocks likely to be in focus today.

Top Stocks to Watch on November 5, 2025

  • TCS: Expanded its 18-year partnership with ABB to modernize IT and boost digital operations.

  • Mahindra & Mahindra (M&M): To sell its entire 3.45% stake in RBL Bank for about ₹680 crore.

  • RBL Bank: Stake sale floor price set at ₹317 per share.

  • Britannia Industries: Strong EBITDA growth; appoints Rakshit Hargave as CEO & Executive Director.

  • Sun Pharma: Q1 revenue in line with estimates; operational performance beats expectations.

  • Aurobindo Pharma: Q2 results meet estimates; Europe formulations revenue up 17.8% YoY.

  • Indigo: Operationally steady, but profit hit by forex losses.

  • Paytm: Revenue up across all segments; margin improves 317 bps QoQ.

  • United Spirits (USL): Begins strategic review of its sports arm, RCSPL, which owns RCB.

  • Indian Hotels: Seasonally soft quarter; guidance remains strong for H2.

  • Zydus Lifesciences: Receives EIR from USFDA for Ahmedabad SEZ-II facility.

  • Marksans Pharma: UK arm Relonchem gets MHRA nod for Exemestane 25mg tablets.

  • Garden Reach: Revenue up 45.5% YoY, margins expand to 9.3%.

  • Metropolis Health: EBITDA up 20.5%, revenue up 23% YoY.

  • Kaynes Technology: EBITDA up 80.6%, margin improves to 16.3%.

  • Home First Finance: Net profit rises 43%, NII up 32% YoY.

  • Apollo Micro Systems: EBITDA surges 82.7%, margin expands to 26.45%.

  • Caplin Point: EBITDA up 15%, margin at 35.4%.

  • CSB Bank: NII rises 15.3%, Gross NPA improves to 1.81%.

  • Inox Wind: Wins 229 MW orders, including repeat deals.

  • Blue Star: Revenue up 6%, margin expands by 100 bps.

  • Hindalco: Novelis Q2 results weak as expected; capex guidance raised.

  • Grasim: Margin contracts to 3.8%; Birla Opus CEO resigns.

  • Fortis, GE Vernova, Siemens Energy: Added to MSCI India Standard Index.

  • Tata Elxsi, CONCOR: Dropped from MSCI India Index.

  • Berger Paints: EBITDA down 19%, margin falls to 12.5%.

  • Whirlpool: Net profit down 20.6%, margin at 3.5%.

  • Jubilant Pharmova: USFDA issues 9 observations for its Montreal unit.

  • Senores Pharma: US unit gets 3 USFDA observations.

  • Dalmia Bharat: EBITDA down 16.8%, margin falls to 5.6%.

  • Deepak Fertilisers: EBITDA down 6%, margin slips to 15.4%.

  • Godrej Agrovet: EBITDA down 2%, margin at 8.3%.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

TOPICS: Aurobindo Pharma Britannia Industries M&M Paytm RBL Bank TCS